Oculotronics, a Guangzhou-based developer of ophthalmic surgical robots, has reportedly raised tens of millions of renminbi in a pre-Series A financing round. The funds raised will be allocated towards the clinical study and industrialization of its flagship product, a micron-level high-precision ophthalmic surgical robot. Additionally, the capital will support the development of the company’s comprehensive suite of microsurgical procedures for ophthalmology.
Oculotronics’ Focus on High-Precision Ophthalmic Devices
Established in 2020, Oculotronics is dedicated to the advancement of high-precision, intelligent, and automated “femtosecond-like” devices designed to facilitate complex fundus surgeries. The company’s mission is to enhance surgical precision and efficiency in the field of ophthalmology, leveraging cutting-edge robotic technology.- Flcube.com
